H
Y
P
E
R
I
N
S
U
L
I
N
A
E
M
I
A
ISSN 1811-6515
THE SOUTH AFRICAN JOURNAL OF
Diabetes & vascular disease
Corresponding Editor
PROF WF MOLLENTZE
Head of the Department of Internal
Medicines, University of the Free State,
Bloemfontein
Consulting Editors
PROF J-C MBANYA
PROF AJ BRINK
National Editorial Board
DR A AMOD
Centre for Diabetes, Endocrinology and
Metabolic Diseases, Life Healthcare,
Chatsmed Gardens Hospital, Durban
SR K BECKERT
Diabetes Nurse, Paarl
PROF F BONNICI
Emeritus Professor, Faculty of Health
Sciences, University of Cape Town and
President of Diabetes South Africa
PROF R DELPORT
Department of Family Medicine,
University of Pretoria
DR L DISTILLER
Director of the Centre of Diabetes
and Endocrinology, Houghton,
Johannesburg
DR F MAHOMED
Department of Endocrinology,
Grey’s Hospital, Pietermaritzburg
PROF CD POTGIETER
Specialist Nephrologist, University
of Pretoria and Jakaranda Hospital,
Pretoria
PROF K SLIWA
Associate Professor of Medicine and
Cardiology, Baragwanath Hospital,
University of the Witwatersrand, Johan-
nesburg
PROF YK SEEDAT
Emeritus Professor of Medicine and
Honorary Research Associate,
University of Natal, Durban
International Editorial Board
PROF IW CAMPBELL
Physician, Victoria Hospital, Kircaldy,
Scotland, UK
PROF PJ GRANT
Professor of Medicine and head of
Academic Unit of Molecular Vascular
Medicine, Faculty of Medicine and
Health, University of Leeds; honorary
consultant physician, United Leeds
Teaching Hospitals NHS Trust, UK
PROF J-C MBANYA
Professor of Endocrinology, Faculty of
Medicine and Biomedical Sciences,
University of Yaounde I, Cameroon
and President, International Diabetes
Federation
PROF N POULTER
Professor of Preventive Cardiovascular
Medicine, Imperial College, School of
Medicine, London, UK
DR H PURCELL
Senior Research Fellow in Cardiology,
Royal Brompton National Heart and
Lung Hospital, London, UK
VOLUME 8 NUMBER 1 • MARCH 2011
CONTENTS
Editorial
4
Insulin therapy in South Africa: barriers, dilemmas and paradoxes
WF Mollentze
Reviews
5
Vitiligo
BB Adamjee
10
Genetic counselling in type 1 diabetes mellitus
BD Henderson
14
Diabetes and thyroid disorders
G Brenta
19
The new world of biosimilars: what diabetologists need to know about
biosimilar insulins
I Krämer, T Sauer
Patient Information Leaflet
26
You and your thyroid supplement
PM van Zyl
Diabetes Personality
27
A passion for people
Cardiovascular Focus
29
Extracts from the 11th annual South
African Heart Association Congress,
August 2010
G Visagie
It's the
shell that
makes
safer.
R
Safety-Coated
R
81mg
The ORIGINAL low dose aspirin
for optimum cardio-protection
Hp
Each tablet contains Aspirin 81mg. Reg.No.: 29/2.7/0767
Pharmafrica (Pty) Ltd, 33 Hulbert Road, New Centre, Johannesburg 2001
Under licence from Goldshield Pharmaceuticals Ltd. U.K.
